JPH06506198A
(ja)
*
|
1991-03-04 |
1994-07-14 |
ワーナー−ランバート・コンパニー |
種々な剤形の非ステロイド性抗炎症剤の新規な塩/イオン対
|
JPH069382A
(ja)
*
|
1992-04-17 |
1994-01-18 |
Takeda Chem Ind Ltd |
安定化された固型製剤およびその製造方法
|
ZA933725B
(en)
*
|
1992-05-28 |
1993-12-15 |
Elan Corp Plc |
Tablet formulation
|
US5314697A
(en)
*
|
1992-10-23 |
1994-05-24 |
Schering Corporation |
Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
|
CA2151912A1
(fr)
*
|
1992-12-21 |
1994-07-07 |
Richard Wilfred D'souza |
Utilisation d'antipodes s(+) d'agents analgesiques pour la preparation d'une composition permettant de traiter les troubles respiratoires
|
AU675557B2
(en)
*
|
1993-06-14 |
1997-02-06 |
Janssen Pharmaceutica N.V. |
Extended release, film-coated tablet of astemizole and pseudoephedrine
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
US6676967B1
(en)
*
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
US6080428A
(en)
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
US6129930A
(en)
|
1993-09-20 |
2000-10-10 |
Bova; David J. |
Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
|
US20060263428A1
(en)
*
|
1993-09-20 |
2006-11-23 |
Eugenio Cefali |
Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
US7214683B1
(en)
|
1994-12-30 |
2007-05-08 |
Sepracor Inc. |
Compositions of descarboethoxyloratadine
|
US7211582B1
(en)
|
1994-12-30 |
2007-05-01 |
Sepracor Inc. |
Methods for treating urticaria using descarboethoxyloratadine
|
PT812195E
(pt)
*
|
1995-02-28 |
2003-03-31 |
Aventis Pharma Inc |
Composicao farmaceutica para compostos de piperidinoalcanol
|
US6645988B2
(en)
*
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6469009B1
(en)
*
|
1996-04-08 |
2002-10-22 |
Ucb, S.A. |
Pharmaceutical compositions for the treatment of rhinitis
|
ES2248847T3
(es)
*
|
1996-05-24 |
2006-03-16 |
Angiotech Pharmaceuticals, Inc. |
Composiciones y metodos para tratar o prevenir enfermedades de las vias de conduccion del cuerpo.
|
NZ335078A
(en)
*
|
1996-10-31 |
2000-10-27 |
Schering Corp |
Composition, for the treatment of asthma, containing loratadine and a decongestant
|
US6160020A
(en)
*
|
1996-12-20 |
2000-12-12 |
Mcneill-Ppc, Inc. |
Alkali metal and alkaline-earth metal salts of acetaminophen
|
AU776837B2
(en)
*
|
1997-02-07 |
2004-09-23 |
Sunovion Pharmaceuticals Inc. |
Lactose-free non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
|
PE71699A1
(es)
*
|
1997-02-07 |
1999-08-03 |
Sepracor Inc |
Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
|
CA2281473C
(fr)
|
1997-02-20 |
2007-01-16 |
Therics, Inc. |
Forme galenique presentant des proprietes de dispersion rapide, ses procedes d'utilisation et son procede de preparation
|
BE1011045A3
(fr)
|
1997-03-14 |
1999-04-06 |
Ucb Sa |
Compositions pharmaceutiques pour la liberation controlee de substances actives.
|
US7179486B1
(en)
|
1997-04-01 |
2007-02-20 |
Nostrum Pharmaceuticals, Inc. |
Process for preparing sustained release tablets
|
US5895663A
(en)
*
|
1997-07-31 |
1999-04-20 |
L. Perrigo Company |
Pseudoephedrine hydrochloride extended-release tablets
|
SI0998272T1
(en)
*
|
1997-08-26 |
2003-12-31 |
Aventis Pharmaceuticals Inc. |
Pharmaceutical composition for combination of piperidinoalkanol-decongestant
|
EP2055303A3
(fr)
*
|
1998-07-10 |
2009-12-16 |
Schering Corporation |
Compositions orales à base de 8-chloro-6,11-dihydro-11-(4-piperidylene)-5H-benzo[5,6]cyclo-hepta[1,2-b]pyridine
|
CO5271713A1
(es)
*
|
1998-09-10 |
2003-04-30 |
Schering Corp |
Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
|
US6521254B2
(en)
|
1998-12-07 |
2003-02-18 |
J-Med Pharmaceuticals, Inc. |
Single-dose antihistamine/decongestant formulations for treating rhinitis
|
KR100505899B1
(ko)
*
|
1999-02-23 |
2005-08-01 |
주식회사유한양행 |
로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
|
US6211246B1
(en)
|
1999-06-10 |
2001-04-03 |
Mcneil-Ppc, Inc. |
Rapidly absorbed liquid compositions
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6100274A
(en)
*
|
1999-07-07 |
2000-08-08 |
Schering Corporation |
8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
|
US6264983B1
(en)
*
|
1999-09-16 |
2001-07-24 |
Rhodia, Inc. |
Directly compressible, ultra fine acetaminophen compositions and process for producing same
|
US6267986B1
(en)
|
1999-09-24 |
2001-07-31 |
Ranbaxy Laboratories Limited |
Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
|
US6114346A
(en)
|
1999-10-22 |
2000-09-05 |
Schering Corporation |
Treating sleep disorders using desloratadine
|
AU2277101A
(en)
*
|
1999-12-20 |
2001-07-03 |
Schering Corporation |
Stable extended release oral dosage composition
|
AU2276801A
(en)
|
1999-12-20 |
2001-07-03 |
Schering Corporation |
Extended release oral dosage composition
|
US6613357B2
(en)
*
|
2000-01-13 |
2003-09-02 |
Osmotica Corp. |
Osmotic device containing pseudoephedrine and an H1 antagonist
|
DE10003757A1
(de)
*
|
2000-01-28 |
2001-08-02 |
Knoll Ag |
Ibuprofen-Wirkstoffzubereitung
|
US7405223B2
(en)
|
2000-02-03 |
2008-07-29 |
Schering Corporation |
Treating allergic and inflammatory conditions
|
AU2000242484B2
(en)
*
|
2000-04-14 |
2006-02-09 |
J-Med Pharmaceuticals, Inc. |
Single-dose antihistamine/decongestant formulations for treating rhinitis
|
ES2185452B2
(es)
*
|
2000-08-01 |
2004-03-16 |
Cinfa S A Lab |
Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
|
AU2002220248A1
(en)
*
|
2000-11-06 |
2002-05-15 |
Andrx Pharmaceuticals, Inc. |
Once a day antihistamine and decongestant formulation
|
US6982251B2
(en)
*
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
CA2434169C
(fr)
|
2001-01-12 |
2011-03-15 |
Sun Pharmaceutical Industries Limited |
Systeme de liberation espacee de medicaments
|
US7071181B2
(en)
*
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
SI1353696T1
(sl)
*
|
2001-01-26 |
2007-04-30 |
Schering Corp |
Kombinacije aktivatorja(-ev) peroksisomskega proliferatorja aktivirajocega receptorja (PPAR) in inhibitorja(-ev) absorpcije sterola in oblike zdravljenja za vaskularne indikacije
|
JP2004517920A
(ja)
*
|
2001-01-26 |
2004-06-17 |
シェーリング コーポレイション |
血管状態を治療するためのステロール吸収阻害剤と血液調整剤との組合せ
|
PL205343B1
(pl)
*
|
2001-01-26 |
2010-04-30 |
Schering Corp |
Zastosowanie inhibitora wchłaniania sterolu
|
US20060287254A1
(en)
*
|
2001-01-26 |
2006-12-21 |
Schering Corporation |
Use of substituted azetidinone compounds for the treatment of sitosterolemia
|
TW200840563A
(en)
*
|
2001-01-26 |
2008-10-16 |
Schering Corp |
Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(S) and treatments for vascular indications
|
ES2287250T3
(es)
*
|
2001-01-26 |
2007-12-16 |
Schering Corporation |
Combinaciones de secuestrante(s) de acidos biliares e inhibidor(es) de la absorcion de esteroles y tratamientos para indicaciones vasculares.
|
CZ20032031A3
(cs)
*
|
2001-01-26 |
2003-12-17 |
Schering Corporation |
Farmaceutický prostředek
|
RU2324475C2
(ru)
*
|
2001-04-10 |
2008-05-20 |
Сан Фармасьютикал Индастриз Лимитед |
Состав, выделяемый в импульсном режиме в заданное время
|
US20030013699A1
(en)
*
|
2001-05-25 |
2003-01-16 |
Davis Harry R. |
Methods for treating alzheimer's disease and/or regulating levels of amyloid beta peptides in a subject
|
CN1518448A
(zh)
*
|
2001-06-20 |
2004-08-04 |
���鹫˾ |
用于治疗鼻充血和鼻塞的抗组胺剂
|
AU2002320309B2
(en)
*
|
2001-07-06 |
2007-07-12 |
Endo Pharmaceuticals, Inc. |
Oxymorphone controlled release formulations
|
US6720002B2
(en)
|
2001-07-20 |
2004-04-13 |
R.P. Scherer Technologies, Inc. |
Antihistamine formulations for soft capsule dosage forms
|
US7056906B2
(en)
*
|
2001-09-21 |
2006-06-06 |
Schering Corporation |
Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
|
US7053080B2
(en)
*
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
CA2460340C
(fr)
*
|
2001-09-21 |
2011-02-15 |
Schering Corporation |
Methodes et combinaisons therapeutiques utiles pour le traitement du xanthome effectue avec des inhibiteurs d'absorption du sterol
|
US20030119808A1
(en)
*
|
2001-09-21 |
2003-06-26 |
Schering Corporation |
Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
|
HUP0401501A3
(en)
*
|
2001-09-21 |
2012-02-28 |
Schering Corp |
Treating or preventing vascular inflammation using pharmaceutical compositions containing sterol absorption inhibitor(s)
|
US6837696B2
(en)
*
|
2001-09-28 |
2005-01-04 |
Mcneil-Ppc, Inc. |
Apparatus for manufacturing dosage forms
|
US7838026B2
(en)
|
2001-09-28 |
2010-11-23 |
Mcneil-Ppc, Inc. |
Burst-release polymer composition and dosage forms comprising the same
|
BR0212946A
(pt)
*
|
2001-09-28 |
2004-10-26 |
Mcneil Ppc Inc |
Formas de dosagens de liberação modificada
|
US7122143B2
(en)
|
2001-09-28 |
2006-10-17 |
Mcneil-Ppc, Inc. |
Methods for manufacturing dosage forms
|
AR040588A1
(es)
*
|
2002-07-26 |
2005-04-13 |
Schering Corp |
Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
|
CA2504878A1
(fr)
*
|
2002-11-06 |
2004-05-27 |
Schering Corporation |
Inhibiteurs d'absorption du cholesterol pour le traitement de la demyelination
|
US8092831B2
(en)
*
|
2002-11-08 |
2012-01-10 |
Andrx Pharmaceuticals, Llc |
Antihistamine and decongestant system
|
US7863287B2
(en)
*
|
2002-12-18 |
2011-01-04 |
Wyeth Llc |
Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
|
US20040253311A1
(en)
*
|
2002-12-18 |
2004-12-16 |
Roger Berlin |
Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
|
US20040142903A1
(en)
*
|
2003-01-16 |
2004-07-22 |
Par Pharmaceutical Inc. |
Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions
|
US7459442B2
(en)
*
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
EP1606287B1
(fr)
|
2003-03-07 |
2013-10-02 |
Merck Sharp & Dohme Corp. |
Composés d'azetidinone substitués, formulations et utilisations de ceux-ci pour traiter l'hypercholestérolémie
|
CN100439361C
(zh)
|
2003-03-07 |
2008-12-03 |
先灵公司 |
取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
|
EP1601669B1
(fr)
*
|
2003-03-07 |
2008-12-24 |
Schering Corporation |
Composes d'azetidinone substitues, leurs formulations et leur utilisation pour traiter l'hypercholesterolemie
|
DE602004018161D1
(de)
*
|
2003-07-28 |
2009-01-15 |
Mallinckrodt Inc |
Verbesserte stearat-zusammensetzung und herstellungsverfahren dafür
|
EP1708684A2
(fr)
*
|
2003-09-26 |
2006-10-11 |
Alza Corporation |
Enrobage de medicaments a charge medicamenteuse elevee et procedes de fabrication
|
JP2007510659A
(ja)
*
|
2003-11-05 |
2007-04-26 |
シェーリング コーポレイション |
脂質調節剤および置換アゼチジノンの組み合わせならびに血管状態の処置
|
US20050266032A1
(en)
*
|
2003-12-17 |
2005-12-01 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
US8188067B2
(en)
|
2004-04-01 |
2012-05-29 |
Teva Pharmaceutical Industries Ltd. |
Formulations of 6-mercaptopurine
|
US20070077297A1
(en)
*
|
2004-09-30 |
2007-04-05 |
Scolr Pharma, Inc. |
Modified release ibuprofen dosage form
|
US20060068009A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Scolr Pharma, Inc. |
Modified release ibuprofen dosage form
|
US20070036859A1
(en)
*
|
2005-08-11 |
2007-02-15 |
Perry Ronald L |
Sustained release antihistamine and decongestant composition
|
CN104161736A
(zh)
|
2006-06-01 |
2014-11-26 |
Msd消费保健品公司 |
包含去氧肾上腺素的缓释药物制剂
|
CA2653950A1
(fr)
*
|
2006-06-01 |
2007-12-13 |
Schering Corporation |
Formulations et compositions pharmaceutiques a liberation pulsee de phenylephrine
|
US7749537B2
(en)
*
|
2006-12-04 |
2010-07-06 |
Scolr Pharma, Inc. |
Method of forming a tablet
|
US8771643B2
(en)
*
|
2008-01-04 |
2014-07-08 |
Schabar Research Associates Llc |
Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound
|
US20130115250A1
(en)
*
|
2009-05-13 |
2013-05-09 |
Wyeth Llc |
Burst Drug Release Compositions
|
US20110104272A1
(en)
*
|
2009-11-05 |
2011-05-05 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of acetaminophen and phenylephrine
|
CA2690490C
(fr)
|
2010-01-19 |
2012-06-26 |
Accucaps Industries Limited |
Formulations pharmaceutiques de loratadine pour encapsulation et combinaisons associees
|
JP5752578B2
(ja)
*
|
2011-12-09 |
2015-07-22 |
ジェイ−メド ファーマシューティカルズ,インコーポレーティッド |
鼻炎治療のための単一投与抗ヒスタミン薬/鬱血除去薬製剤
|
EP2727592A1
(fr)
*
|
2012-11-05 |
2014-05-07 |
Kücükgüzel, Sükriye Güniz |
Combinaison de desloratadine et de paracétamol
|
LT3086793T
(lt)
|
2013-12-24 |
2022-08-25 |
Virginia Commonwealth University |
Deguonimi įsodrintų cholesterolio sulfatų (ocs) naudojimas inkstų disfunkcijai gydyti
|
EP3362053A4
(fr)
|
2015-10-16 |
2019-04-17 |
Hadasit Medical Research Services and Development Ltd. |
Traitement de la maladie du foie gras non alcoolique ou de la stéatohépatite non alcoolique avec de la 6-mercaptopurine à libération retardée
|
CA3124579A1
(fr)
|
2020-07-15 |
2022-01-15 |
Schabar Research Associates Llc |
Compositions de doses orales unitaires composees de naproxene sodique et de famotidine pour le traitement des douleurs aigues et la reduction de la gravite des aigreurs et/ou du risque d'aigreurs
|
US11331307B2
(en)
|
2020-07-15 |
2022-05-17 |
Schabar Research Associates, Llc |
Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn
|
EP4188339A1
(fr)
|
2020-07-30 |
2023-06-07 |
Faes Farma, S.A. |
Système d'administration de médicaments décongestionnants
|